검색결과 : 11건
| No. | Article |
|---|---|
| 1 |
Insights into the limitations of transient expression systems for the functional study of p53 acetylation site and oncogenic mutants Bruer M, Reinhardt D, Welte K, Thakur BK Biochemical and Biophysical Research Communications, 524(4), 990, 2020 |
| 2 |
DHPS-dependent hypusination of eIF5A1/2 is necessary for TGF beta/fibronectin-induced breast cancer metastasis and associates with prognostically unfavorable genomic alterations in TP53 Guth R, Adamian Y, Geller C, Molnar J, Maddela J, Kutscher L, Bhakta K, Meade K, Kim SL, Agajanian M, Kelber JA Biochemical and Biophysical Research Communications, 519(4), 838, 2019 |
| 3 |
JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer Danielpour D, Purighalla S, Wang E, Zmina PM, Sarkar A, Zhou G Biochemical and Biophysical Research Communications, 518(2), 374, 2019 |
| 4 |
Cross talk between TP53 and c-Myc in the pathophysiology of Diamond-Blackfan anemia: Evidence from RPL11-deficient in vivo and in vitro models Chakraborty A, Uechi T, Nakajima Y, Gazda HT, O'Donohue MF, Gleizes PE, Kenmochi N Biochemical and Biophysical Research Communications, 495(2), 1839, 2018 |
| 5 |
Dihydroartemisinin potentiates antitumor activity of 5-fluorouracil against a resistant colorectal cancer cell line Yao ZH, Bhandari A, Wang YH, Pan YY, Yang F, Chen RF, Xia EJ, Wang OC Biochemical and Biophysical Research Communications, 501(3), 636, 2018 |
| 6 |
TP53 gene status is a critical determinant of phenotypes induced by ALKBH3 knockdown in non-small cell lung cancers Kogaki T, Ohshio I, Kawaguchi M, Kimoto M, Kitae K, Hase H, Ueda Y, Jingushi K, Tsujikawa K Biochemical and Biophysical Research Communications, 488(2), 285, 2017 |
| 7 |
The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer Brachova P, Thiel KW, Leslie KK International Journal of Molecular Sciences, 14(9), 19257, 2013 |
| 8 |
Validation of whole genome amplification for analysis of the p53 tumor suppressor gene in limited amounts of tumor samples Hasmats J, Green H, Solnestam BW, Zajac P, Huss M, Orear C, Validire P, Bjursell M, Lundeberg J Biochemical and Biophysical Research Communications, 425(2), 379, 2012 |
| 9 |
TP53 and P21 polymorphisms: Response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer Santos AM, Sousa H, Portela C, Pereira D, Pinto D, Catarino R, Rodrigues C, Araujo AP, Lopes C, Medeiros R Biochemical and Biophysical Research Communications, 340(1), 256, 2006 |
| 10 |
p53 mutation heterogeneity in cancer Soussi T, Lozano G Biochemical and Biophysical Research Communications, 331(3), 834, 2005 |